Back to medications
Medication monograph

tocilizumab

Interleukin-6 (IL-6) Receptor AntagonistsImmunomodulatorsMonoclonal AntibodiesDisease-modifying Antirheumatic AgentsInterleukin-6 Receptor AntagonistImmunomodulatory AgentsDisease-modifying Antirheumatic Drugs

Clinical reference

Product monograph

TOFIDENCE- tocilizumab injection

TOCILIZUMAB-ANOH- tocilizumab injection, solution, concentrate

Brands & formulations

Family members

ACTEMRA

Marketed
80 MGINTRAVENOUSSOLUTION[ "tocilizumab" ]
Product monograph

ACTEMRA

Marketed
200 MGINTRAVENOUSSOLUTION[ "tocilizumab" ]
Product monograph

ACTEMRA

Marketed
400 MGINTRAVENOUSSOLUTION[ "tocilizumab" ]
Product monograph

ACTEMRA

Marketed
162 MGSUBCUTANEOUSSOLUTION[ "tocilizumab" ]
Product monograph

ACTEMRA

Marketed
162 MGSUBCUTANEOUSSOLUTION[ "tocilizumab" ]
Product monograph

TYENNE

Marketed
80 MGINTRAVENOUSSOLUTION[ "tocilizumab" ]
Product monograph

TYENNE

Marketed
200 MGINTRAVENOUSSOLUTION[ "tocilizumab" ]
Product monograph

TYENNE

Marketed
400 MGINTRAVENOUSSOLUTION[ "tocilizumab" ]
Product monograph

TYENNE

Marketed
162 MGSUBCUTANEOUSSOLUTION[ "tocilizumab" ]
Product monograph

TYENNE

Marketed
162 MGSUBCUTANEOUSSOLUTION[ "tocilizumab" ]
Product monograph

Classification

Chemical class
Interleukin-6 (IL-6) Receptor Antagonists
Clinical class
Immunomodulators, Monoclonal Antibodies
Banks class
Disease-modifying Antirheumatic Agents, Interleukin-6 Receptor Antagonist
AHFS family
Immunomodulatory Agents, Disease-modifying Antirheumatic Drugs